Pharmacogenomic Nomenclature

Dr. Magnus Ingelman-Sundberg presents his recent paper on "Pharmacogenomic biomarkers for prediction of "severe adverse drug reactions" published in the New England Journal of Medicine on Feb 2008.

A visiting graduate student at Stanford University explains his research with Professor Russ Altman.